In a human MTC cell line, the TT cells, IGF-I increases cell proliferation, DNA synthesis, and the percentage of cells in S phase, all effects counteracted by co-incubation with either an IGF-I antibody or an IGF-I receptor (IGF-I R) antibody (4). The gene discussed is IGF1R; the disease is medullary thyroid gland carcinoma.